The comparative effectiveness and safety of four second-line antihyperglycemic drugs in type 2 diabetes mellitus: an international multi-centre cohort study
The comparative effectiveness and safety of four second-line antihyperglycemic drugs in type 2 diabetes mellitus: an international multi-centre cohort study
四种二线降糖药治疗 2 型糖尿病的有效性和安全性比较：一项国际多中心队列研究
批准号：
454462
负责人：
Abrahami Devin
金额：
$7.29万
依托单位国家：
加拿大
项目类别：
Fellowship Programs
财政年份：
2021
资助国家：
加拿大
项目状态：
已结题
起止时间：
2021-10-01 至 2023-10-01
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The treatment landscape for type 2 diabetes mellitus has significantly changed in the last decade with the introduction of several new drug classes. These include dipeptidyl peptidase-4 inhibitors (DPP-4I), glucagon-like peptide-1 receptor agonists (GLP-1
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Sodium-glucose co-transporter 2 inhibitors and bladder cancer - a causal association or detection bias? An international multicenter cohort study.
-
批准号：396360
-
项目类别：Studentship Programs
-
资助金额：$10.93万
-
财政年份：2018
-
负责人：Abrahami Devin
-
依托单位：
海外基金
